BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7318924)

  • 21. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
    Høisaeter PA
    Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiprostatic effects of a nitrogen mustard of estriol.
    Varkarakis MJ; Kirdani RY; Murphy GP; Sandberg AA
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):904-8. PubMed ID: 1129313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Prog Clin Biol Res; 1981; 75A():391-407. PubMed ID: 7339627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T; Haukaas S
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estramustine-binding protein in rat and human prostate.
    Forsgren B
    Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histochemical and ultrastructural study of prostatic tissue from baboons treated with antiprostatic drugs.
    Müntzing J; Myhrberg H; Saroff J; Sandberg AA; Murphy GP
    Invest Urol; 1976 Sep; 14(2):162-7. PubMed ID: 823125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of drug-vinyl copolymer delivery composites on the rat prostate.
    Yoshida M; Asano M; Kaetsu I; Yamanaka H; Nakai K; Yuasa H; Shida K
    J Biomed Mater Res; 1985; 19(6):615-29. PubMed ID: 2416759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of testosterone on estracyt localization in rat prostate.
    Catane R; Mittelman A; Murphy GP; Sandberg AA
    Oncology; 1980; 37(5):357-9. PubMed ID: 7443167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3149-53. PubMed ID: 290993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the conversion of oestradiol linked to a cytostatic agent (Estracyt) in various rat tissues.
    Hoisaeter PA
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):661-72. PubMed ID: 947135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of estramustine phosphate upon testosterone-induced cell proliferation in accessory sex glands of mice [proceedings].
    Alison MR; Wright NA
    J Endocrinol; 1979 Oct; 83(1):33P-34P. PubMed ID: 521712
    [No Abstract]   [Full Text] [Related]  

  • 38. Accumulation of estramustine and estromustine in adipose tissue of rats and humans.
    Gunnarsson PO; Andersson SB; Sandberg AA; Ellman M
    Cancer Chemother Pharmacol; 1991; 28(5):361-4. PubMed ID: 1914079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerve.
    Kanje M; Deinum J; Wallin M; Ekström P; Edström A; Hartley-Asp B
    Cancer Res; 1985 May; 45(5):2234-9. PubMed ID: 2580617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estramustine affects bone mineral metabolism in metastatic prostate cancer.
    Citrin DL; Wallemark CB; Nadler R; Geiger C; Tuttle K; Kaplan EH; Hauck W
    Cancer; 1986 Nov; 58(10):2208-13. PubMed ID: 3756769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.